Today all chip designs begin as lines of code. The code is written at a high level, hiding much of the complexity from the designer, and then synthesized into a low-level description for layout and ...
Stop at any booth at the Embedded Systems Conference and you'll see a demo of the latest and greatest tool for accelerating the time to market for your latest project. Just like Moore's Law has ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it ...
Synthesis has been named a winner of the 2025 Sub-Saharan Africa AWS Regional Partner Award. AWS Regional Partner Awards recognize AWS’s Top Partners of the Year and Rising Star Partners of the Year ...
TipRanks on MSN
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
The Peptide-ExplorerLT ™ is designed for scientists who need to optimize and explore linear peptide synthesis. The product is a high-spec flow chemistry system that uses continuous flow. The product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback